ARKK vs. CNCR ETF Comparison

Comparison of ARK Innovation ETF (ARKK) to Loncar Cancer Immunotherapy ETF (CNCR)
ARKK

ARK Innovation ETF

ARKK Description

The investment seeks long-term growth of capital. The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 65% of its assets) in domestic and foreign equity securities of companies that are relevant to the fund's investment theme of disruptive innovation. Its investments in foreign equity securities will be in both developed and emerging markets. The fund currently intends to use only American Depositary Receipts ("ADRs") when purchasing foreign securities. It is non-diversified.

Grade (RS Rating)

Last Trade

$44.80

Average Daily Volume

11,877,902

Number of Holdings *

36

* may have additional holdings in another (foreign) market
CNCR

Loncar Cancer Immunotherapy ETF

CNCR Description ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.

Grade (RS Rating)

Last Trade

$15.55

Average Daily Volume

44,751

Number of Holdings *

71

* may have additional holdings in another (foreign) market
Performance
Period ARKK CNCR
30 Days -11.01% -5.22%
60 Days -14.31% -13.45%
90 Days -4.80% 6.12%
12 Months 26.60% 20.44%
2 Overlapping Holdings
Symbol Grade Weight in ARKK Weight in CNCR Overlap
DNA F 1.75% 1.12% 1.12%
RXRX D 1.8% 1.03% 1.03%
ARKK Overweight 34 Positions Relative to CNCR
Symbol Grade Weight
TSLA C 12.32%
COIN D 8.54%
ROKU F 8.31%
SQ D 6.71%
PATH F 5.62%
CRSP F 4.57%
RBLX D 4.41%
HOOD D 4.01%
ZM F 3.91%
U D 3.43%
PLTR C 2.96%
SHOP D 2.94%
DKNG C 2.59%
NTLA D 2.43%
PDFS F 2.19%
TXG F 1.94%
TDOC F 1.94%
TTD B 1.85%
TWST C 1.83%
META D 1.8%
BEAM F 1.78%
TER A 1.52%
PINS B 1.43%
EXAS F 1.39%
VCYT D 1.21%
MRNA A 1.19%
ACHR D 1.01%
SOFI F 1.0%
PACB F 0.47%
CERS D 0.3%
NTRA A 0.26%
VERV F 0.26%
PRME F 0.18%
TWOU F 0.0%
ARKK Underweight 69 Positions Relative to CNCR
Symbol Grade Weight
GERN A -2.87%
ACRV B -2.63%
ELVN A -2.13%
JANX A -1.79%
NUVB A -1.7%
CGEM A -1.57%
RVMD A -1.56%
HCM A -1.54%
TSVT D -1.51%
DAWN A -1.5%
BPMC A -1.48%
MRK A -1.48%
EXEL B -1.47%
LYEL C -1.46%
YMAB B -1.43%
MOR C -1.41%
BCYC B -1.39%
PGEN C -1.39%
INBX C -1.38%
ITOS B -1.38%
IMCR D -1.37%
MGNX C -1.37%
NRIX D -1.37%
IPHA C -1.36%
AURA D -1.34%
BNTX D -1.33%
REGN C -1.33%
RAPT F -1.32%
GMAB D -1.32%
MRUS B -1.32%
VOR F -1.32%
BMY F -1.31%
SDGR F -1.31%
SNDX C -1.29%
DCPH A -1.29%
ACET F -1.28%
TYRA B -1.27%
ERAS D -1.27%
GLUE C -1.26%
IDYA C -1.25%
KYMR C -1.25%
SWTX C -1.23%
PRLD D -1.22%
FHTX C -1.21%
XNCR B -1.21%
STRO D -1.21%
KURA C -1.2%
IMTX D -1.19%
RCUS D -1.18%
ZNTL F -1.17%
IOVA C -1.16%
KPTI F -1.14%
NUVL C -1.12%
IGMS D -1.1%
RLAY D -1.09%
ACLX D -1.07%
SMMT B -1.06%
AUTL F -1.04%
ARVN D -1.02%
REPL F -1.01%
CRBU F -1.01%
LEGN F -0.96%
ALLO F -0.95%
BMEA F -0.9%
RPTX F -0.89%
FATE D -0.83%
MRSN D -0.81%
GNLX F -0.78%
IMRX F -0.73%
Compare ETFs